Welcome to Breakthrough Investors! Your report is on the way to your inbox!
Check any of the FREE reports below you would like to have sent to you…
Then click “Submit & Continue” to see the small group of stocks going absolutely bananas… We're talking gains of 230%, 379%, even a mind-boggling 865%…in mere months.
Opening Recap Market Pulse: U.S. stocks edged within a tight band yesterday, shrugging off hawkish Fed chatter and ending largely flat. Tech names held ground
Company Overview Gossamer Bio, Inc. (NASDAQ: GOSS) is a clinical-stage biopharmaceutical company focused on developing seralutinib, an inhaled therapy for pulmonary arterial hypertension (PAH) (ir.gossamerbio.com).
Opening Recap Market Pulse: Equities drifted Friday with tech sagging and value names barely moving, setting a lukewarm tone. Key Movers: China’s robot-hand unicorn Linkerbot
